Jacques M T de Bakker, Tobias OptHof. Show Affiliations »
Abstract
Mesh： See more » Action Potentials/drug effectsAction Potentials/physiologyAnimalsChromans/pharmacologyDogsHeart/physiologyMyocardial Contraction/drug effectsMyocardial Contraction/physiologyPhenethylamines/pharmacologyPotassium Channel Blockers/pharmacologyPotassium Channels, Inwardly Rectifying/antagonists & inhibitorsSulfonamides/pharmacologyVentricular Function
Substances： See more » ChromansPhenethylaminesPotassium Channel BlockersPotassium Channels, Inwardly RectifyingSulfonamides6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromanedofetilide
Year: 2002 PMID： 11862110 DOI： 10.1097/00005344-200203000-00002
Source DB: PubMed Journal: J Cardiovasc Pharmacol ISSN： 0160-2446 Impact factor: 3.105